EverGlade Consulting Helps Sabin Vaccine Institute Secure up to $214 Million in BARDA Funding to Develop and Procure Ebola Sudan and Marburg Vaccines - EverGlade Consulting

EverGlade Consulting Helps Sabin Vaccine Institute Secure up to $214 Million in BARDA Funding to Develop and Procure Ebola Sudan and Marburg Vaccines

EverGlade Consulting has successfully secured up to $214 million in funding through a contract with BARDA to advance the development and production of single-dose vaccine candidates for Ebola Sudan and Marburg virus diseases.

Featured In:
NY Daily News
US News
Time

AP
Chicago Tribune
The Denver Post
SF Gate

EVERGLADE helps secure BARDA funding for GEOVAX

EverGlade Consulting Helps GeoVax Secure up to $45 Million in BARDA Funding

Read More
office-specific funding opportunities

ARPA-H Announces Mission Office-Specific Funding Opportunities

Read More
Cancer therapy testing

ARPA-H Seeks Revolutionary Solutions for Precision Cancer Therapy Through ADAPT Program

Read More
Scroll to Top